< Back to search
Filter
1
Active & Responsive

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06559059

Recruiting
Active & Responsive

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

for
Primary Central Nervous System Lymphoma
Location: New York NY, Burlington VT, Hershey PA,
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06175000

Phase 2, Recruiting
Active & Responsive

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

for
Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT05800587

Phase 2, Recruiting
Active & Responsive

Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions

for
Premalignant Lesion
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06561087

Phase 2, Recruiting
Active & Responsive

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

for
Breast Cancer Female
Location: New Haven CT, Newport News VA, Richmond VA, Fairfax VA,
Sponsor: University of Virginia

Sex: Female

Age: 65+

Code: NCT06507618

Phase 3, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

for
Tumors Metastatic to Brain
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT01891318

Phase 1, Phase 2, Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Weymouth MA, Boston MA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 60+

Code: NCT06377852

Phase 3, Recruiting
Active & Responsive

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

for
Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 30

Code: NCT05105152

Phase 1, Recruiting
Active & Responsive

Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue

for
Tongue Neoplasms, Tongue Cancer, Oral Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT02584270

Recruiting
Active & Responsive

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

for
Neuroblastoma, Sarcoma
Location: The Bronx NY, Washington D.C. DC, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 40

Code: NCT05135975

Phase 2, Recruiting
Active & Responsive

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: Fairfax VA, Huntersville NC, Nashville TN,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05431270

Phase 1, Phase 2, Recruiting
Active & Responsive

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

for
Prostate Cancer
Location: New York NY
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT06807359

Phase 1, Phase 2, Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase 3, Recruiting
Active & Responsive

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

for
Cervical Cancer, Metastatic Cervical Cancer
Location: Hackensack NJ, Washington D.C. DC, Augusta GA
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04865887

Phase 2, Recruiting
Active & Responsive

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 0+

Code: NCT06145633

Phase 2, Recruiting
Active & Responsive

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

for
Urothelial Carcinoma,
Location: Philadelphia PA, Omaha NE
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06396533

Recruiting
Active & Responsive

PET/CT Characterization of Treatment Resistance

for
Prostate Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT05647564

Recruiting
Active & Responsive

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

for
Barrett Esophagus, Gastroesophageal Reflux,
Location: Baltimore MD, Chapel Hill NC, Cleveland OH, Aurora CO
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 50+

Code: NCT06687603

Recruiting
Active & Responsive

The Utility of FDG-PET for Radiation Treatment in NSCLC

for
Lung Neoplasms, Positron Emission Tomography
Location: Calgary
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00385164

Recruiting
Active & Responsive

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

for
Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1,
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 18+

Code: NCT06395402

Phase 2, Recruiting